Insider Transactions in Q3 2023 at Eli Lilly & CO (LLY)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.52%
|
$5,139
$571.28 P/Share
|
|
Sep 18
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.62%
|
$9,707
$571.28 P/Share
|
|
Sep 18
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.77%
|
$9,707
$571.28 P/Share
|
|
Sep 18
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.16%
|
$14,275
$571.28 P/Share
|
|
Sep 18
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.04%
|
$11,420
$571.28 P/Share
|
|
Sep 18
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.02%
|
$9,707
$571.28 P/Share
|
|
Sep 12
2023
|
Alonzo Weems EVP, ERM & CECO |
SELL
Bona fide gift
|
Direct |
760
-9.79%
|
-
|
|
Sep 12
2023
|
Alonzo Weems EVP, ERM & CECO |
SELL
Open market or private sale
|
Direct |
1,148
-12.89%
|
$677,320
$590.98 P/Share
|
|
Sep 07
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.02%
|
$119,700,000
$570.22 P/Share
|
|
Aug 31
2023
|
Eric Dozier EVP, HR & Diversity |
SELL
Bona fide gift
|
Direct |
546
-8.02%
|
-
|
|
Aug 31
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
46,541
-0.01%
|
$25,830,255
$555.88 P/Share
|
|
Aug 30
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
6,181
-0.0%
|
$3,430,455
$555.74 P/Share
|
|
Aug 29
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
28,747
-0.01%
|
$15,925,838
$554.96 P/Share
|
|
Aug 28
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
37,660
-0.02%
|
$10,444,172,480
$277328.27 P/Share
|
|
Aug 25
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
63,572
-0.02%
|
$35,282,460
$555.22 P/Share
|
|
Aug 24
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
20,992
-0.01%
|
$11,650,560
$555.47 P/Share
|
|
Aug 23
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
1,307
-0.0%
|
$725,385
$555.69 P/Share
|
|
Aug 21
2023
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
600
-10.04%
|
$327,600
$546.51 P/Share
|
|
Aug 21
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.83%
|
$9,900
$550.5 P/Share
|
|
Aug 21
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
26
+0.17%
|
$14,300
$550.5 P/Share
|
|
Aug 21
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.53%
|
$4,950
$550.5 P/Share
|
|
Aug 21
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.03%
|
$9,900
$550.5 P/Share
|
|
Aug 21
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+1.74%
|
$9,900
$550.5 P/Share
|
|
Aug 21
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.04%
|
$11,550
$550.5 P/Share
|
|
Aug 15
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
50,222
-0.01%
|
$27,220,324
$542.8 P/Share
|
|
Aug 14
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
164,778
-0.03%
|
$88,980,120
$540.4 P/Share
|
|
Aug 11
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
83,039
-0.02%
|
$43,927,631
$529.82 P/Share
|
|
Aug 10
2023
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
SELL
Bona fide gift
|
Direct |
249
-0.24%
|
-
|
|
Aug 10
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,000
-0.0%
|
$1,584,000
$528.13 P/Share
|
|
Aug 09
2023
|
David A Ricks President, Chair, and CEO |
SELL
Bona fide gift
|
Direct |
9,550
-2.12%
|
-
|
|
Aug 09
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
123,961
-0.02%
|
$65,699,330
$530.36 P/Share
|
|
Aug 08
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
204,409
-0.01%
|
$106,497,089
$521.62 P/Share
|
|
Jul 21
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
591
-0.0%
|
$275,406
$466.62 P/Share
|
|
Jul 17
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+0.21%
|
$14,304
$447.14 P/Share
|
|
Jul 17
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.65%
|
$4,917
$447.14 P/Share
|
|
Jul 17
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+2.15%
|
$9,834
$447.14 P/Share
|
|
Jul 17
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+1.02%
|
$9,834
$447.14 P/Share
|
|
Jul 17
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.05%
|
$11,175
$447.14 P/Share
|
|
Jul 17
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.03%
|
$9,834
$447.14 P/Share
|